IRRAS Promotes Will Martin to Chief Executive Officer
Having established a strong manufacturing, clinical and regulatory foundation, Company to focus primarily on commercializationStockholm, April 21, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that its Board of Directors has appointed Will Martin as President and Chief Executive Officer (CEO) of the Company. Will Martin, currently the company’s President and Chief Commercial Officer, will assume his new role on July 1, 2021, He will succeed current CEO, Kleanthis G. Xanthopoulos, Ph.D.